导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -22.82% | 1021/1050 |
| 近一周 | -4.08% | 984/1104 |
| 近一月 | -3.71% | 446/1102 |
| 近一季 | -5.77% | 452/1092 |
| 近半年 | -21.46% | 1007/1070 |
| 近一年 | -28.03% | 977/1018 |
| 近两年 | -9.74% | 918/926 |
| 近三年 | -36.68% | 820/834 |
| 成立以来 | 68.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.25% 919/1070 |
-17.19% 1047/1101 |
- - |
- - |
| 2025 | 1.46% 921/1065 |
4.41% 450/1014 |
-2.86% 885/1038 |
4.43% 945/1050 |
-4.21% 679/1065 |
| 2024 | -8.51% 752/1011 |
-1.49% 400/960 |
-7.82% 776/983 |
13.72% 325/991 |
-11.40% 937/1011 |
| 2023 | -17.34% 608/952 |
4.96% 331/880 |
-13.26% 837/895 |
0.85% 63/915 |
-9.96% 857/952 |
| 2022 | -13.79% 148/867 |
-17.76% 414/773 |
18.14% 44/806 |
-12.72% 441/845 |
1.65% 344/867 |
| 2021 | -0.70% 358/740 |
-2.89% 263/580 |
9.69% 364/659 |
-10.40% 520/704 |
4.05% 259/740 |
| 2020 | 72.08% 137/554 |
-1.12% 190/419 |
32.71% 93/466 |
6.14% 341/517 |
23.55% 84/554 |
| 2019 | 69.69% 44/410 |
31.95% 265/1146 |
14.35% 4/1228 |
5.28% 196/390 |
6.83% 283/410 |
| 2018 | -11.07% 11/349 |
- - |
-4.19% 1576/2983 |
-3.56% 1553/2970 |
-5.54% 71/1080 |
| 2017 | 1.10% 175/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 创金合信消费主题股票C VS. 东吴新产业精选股票A(580008) |